Mental Health Updates Go Virtual: Public Gets Partial Invite
Published Date: 4/4/2025
Notice
Summary
The National Institute of Mental Health is holding a virtual meeting on June 17, 2025, where they’ll share updates and discuss important mental health programs. Part of the meeting is open to the public online, while the rest is private to review grant applications. This affects researchers and the public interested in mental health funding and progress, with no cost to join the online session.
Analyzed Economic Effects
4 provisions identified: 3 benefits, 0 costs, 1 mixed.
Open session videocast — no registration
The National Advisory Mental Health Council will hold an open virtual session on June 17, 2025 from 12:00 p.m. to 1:00 p.m. You can watch the open session videocast at http://videocast.nih.gov/ and registration is not required to access the videocast.
Grant application reviews held in closed session
On June 17, 2025 from 1:15 p.m. to 4:00 p.m., the Council meeting will be closed to review and evaluate grant applications and/or proposals under sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.; discussions could disclose confidential trade secrets, commercial property, or personal information.
Reasonable accommodations available if requested
If you plan to view the virtual meeting and need special assistance such as sign language interpretation or other reasonable accommodations, you should notify the Contact Person in advance of the meeting (Contact: Tracy L. Waldeck, Ph.D., Division of Extramural Activities; email: [email protected]).
Public may submit written comments
Any interested person may file written comments with the committee by forwarding a statement (including name, address, telephone, and, if applicable, business or professional affiliation) to the Contact Person listed in the notice.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-05834, Eunice Kennedy Shriver National Institute of Child Health & Human Development; Amended Notice of Meeting
The Eunice Kennedy Shriver National Institute of Child Health & Human Development changed its June 6, 2025 meeting from fully closed to partly open to the public. This means some parts of the meeting will be accessible for people to watch, while others stay private. If you’re interested in child health research, mark your calendar for this important event in Bethesda, MD!
Next: 2025-05839, Agency Information Collection Extension
The Department of Energy is extending a form-collecting process for three more years to keep things running smoothly. This affects anyone who fills out DOE paperwork, but don’t worry—no new fees or big changes are coming. Just a simple extension to keep the info flowing without extra hassle!